The global atherectomy devices industry generated $0.7 billion in 2021, and is anticipated to generate $2.1 billion by 2031, witnessing a CAGR of 10.5% from 2022 to 2031.
The Atherectomy Devices Market refers to the global market for medical devices used in atherectomy procedures. Atherectomy is a minimally invasive procedure used to remove plaque buildup from arteries, primarily in the treatment of peripheral arterial disease (PAD) and coronary artery disease (CAD).
During an atherectomy procedure, a special device is used to cut, shave, or vaporize the plaque in the arteries, restoring blood flow and improving circulation. These devices are typically used when plaque buildup cannot be effectively treated with traditional methods such as medication or angioplasty.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/request-sample/11870
๐๐ซ๐ข๐ฆ๐ ๐๐๐ญ๐๐ซ๐ฆ๐ข๐ง๐๐ง๐ญ๐ฌ ๐จ๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก:
The growth in geriatric population and the rising prevalence of cardiovascular diseases such as coronary artery disease and peripheral artery disease drive the growth of the global atherectomy devices market. However, limited availability of skilled healthcare professionals restricts the market growth. Moreover, use of atherectomy devices in minimally invasive procedures presents new opportunities in the coming years.
๐๐ก๐๐ญ ๐ข๐ฌ ๐ญ๐ก๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐จ๐ ๐๐จ๐ฏ๐ข๐-๐๐ ๐๐๐ง๐๐๐ฆ๐ข๐ ๐จ๐ง ๐๐ญ๐ก๐๐ซ๐๐๐ญ๐จ๐ฆ๐ฒ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฅ๐จ๐๐๐ฅ๐ฅ๐ฒ?
The outbreak of the Covid-19 pandemic had a negative impact on the global atherectomy devices market, owing to a reduction in the number of elective procedures being performed during the lockdown.
Hospitals and healthcare providers had to focus on treating COVID-19 patients, which led to a reduction in the number of non-emergency procedures being performed. This had resulted in a decline in the demand for atherectomy devices during the pandemic.
The rotational atherectomy devices segment to maintain its leadership status throughout the forecast period
The rotational atherectomy devices segment held the highest market share in 2021, accounting for more than one-third of the global atherectomy devices market, and is estimated to maintain its leadership status throughout the forecast period, owing to its high efficiency in removing plaque from the arterial walls due to its rotating burr. However, the directional atherectomy devices segment is projected to manifest the highest CAGR of 11.1% from 2022 to 2031, owing to advancements in directional atherectomy devices.
๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐๐ ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ): https://www.alliedmarketresearch.com/checkout-final/atherectomy-devices-market
๐๐ก๐ ๐ก๐จ๐ฌ๐ฉ๐ข๐ญ๐๐ฅ๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง ๐ข๐ญ๐ฌ ๐ฅ๐๐๐๐๐ซ๐ฌ๐ก๐ข๐ฉ ๐ฌ๐ญ๐๐ญ๐ฎ๐ฌ ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก๐จ๐ฎ๐ญ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐
The hospitals segment held the highest market share in 2021, accounting for more than two-fifths of the global atherectomy devices market, and is estimated to maintain its leadership status throughout the forecast period, owing to the preference for a large number of patients. However, the ambulatory surgery centers segment is projected to manifest the highest CAGR of 10.9% from 2022 to 2031, owing to the affordable price at ambulatory surgery centers.
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐ญ๐จ ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง ๐ข๐ญ๐ฌ ๐๐จ๐ฆ๐ข๐ง๐๐ง๐๐ ๐๐ฒ ๐๐๐๐
North America held the highest market share in terms of revenue in 2021, accounting for more than two-fifths of the global atherectomy devices market, and is likely to dominate the market during the forecast period. This is owing to an increase in adoption of atherectomy devices by patients, rise in awareness about the peripheral artery disease, and surge in healthcare infrastructure. Upsurge in healthcare expenditure in the emerging economies is anticipated to offer lucrative opportunities for the market expansion. However, the Asia-Pacific region is expected to witness the fastest CAGR of 11.9% from 2022 to 2031, owing to factors such as increase in per capita spending, growth in medical tourism, and rise in disposable incomes.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ- https://www.alliedmarketresearch.com/purchase-enquiry/11870
๐๐ญ๐ก๐๐ซ๐๐๐ญ๐จ๐ฆ๐ฒ ๐๐๐ฏ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฒ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ:
Medtronic plc,
Koninklijke Philips N.V.,
Boston Scientific Corporation,
Cardiovascular Systems, Inc.,
Becton,
Dickinson and Company,
AngioDynamics Inc.,
Rex medical,
Nipro Corporation,
Invamed medical,
Avinger Inc.
The report provides a detailed analysis of these key players of the global atherectomy devices market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:
Gene Synthesis Market: https://www.alliedmarketresearch.com/gene-synthesis-market-A39015
Mobile Tomography Market: https://www.alliedmarketresearch.com/mobile-tomography-market-A31901
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
๐๐จ๐ง๐ญ๐๐๐ญ:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com